Scimitar Equity, LLC is an independent equity research firm focused on providing value-added intelligence and insightful investment conclusions on emerging companies demonstrating real progress toward their vision while meeting quarterly expectation.
RegMed Competitive and Market Intelligence 5/4/12, drooping and ill fitted, where is the underwire for the sagging sector
The 6 W’s: Who, what, where, when, why and what of it …
Today’s Gospel: RegMed stocks opened lower and again … still bouncing downward … mid-day, Friday … share pricing is also again …flat in thin trading … with, few leader(s) … no green (ups) and much more red (downs) and 0 black (flats) on the screen. It’s crystal clear that the economic recovery is in doubt …we have an economy that is in need of organic growth and you’re not getting it from these reports. Participation rate dropped and average working hours are down … if you’re lucky enough to have a job, your spending and investing power is still down.
- My favorites: Aastrom (ASTM) is down with a dropping mid-day range ($2.32 – $2.45), with incresed <from yesterday> volume of 220K shares as is Cytori (CYTX) also in a dropping trading range of $2.32 -$2.45 also with greater trading <from yesterday>of 200K and Osiris (OSIR) who is down 1.20% to $4.93 in a trading range of $4.81 – $5.00 on thin 33K volume.
- Minimal upward moves … who isn’t down … in this market condition: Cytomedix (OTC BB: CMXI), BioLife Solutions (OTC BB: BLFS), Geron (GERN) is $0.01 post earnings announcement, Opexa (OPXA), NeoStem (Amex: NBS) is up $0.012 to $0.395 and ReNeuron (RENE.L);
- Minimal downward moves … just about all the rest of the companies in the sector ….
EconRecon: Non-farm payrolls rose much less than expected, with employers adding just 115,000 jobs in April. Economists expected employers to increase hiring by 170,000 workers. Still, the unemployment rate slipped to 8.1%, the lowest since January 2009.
Mid-Day: The NASDAQ is DOWN -58.90 (-1.95%) to 2,965.40 while the Dow is DOWN -160.34 (-1.21%) to 13,046.25.
Mid-Day Market Commentary: With traders reacting negatively to another disappointing jobs report … stocks have moved notably lower in trading on Friday. The major averages have dropped firmly into negative territory, adding to the losses posted in the previous session. Mid-day, the major averages have moved roughly sideways in trading, lingering near their lows.
What’s new in the regenerative medicine/stem cell market … Not much … to know today …
Register here to be notified of future Scimitar Equity articles.